Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2012 April;64(2) > Minerva Pediatrica 2012 April;64(2):197-203

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

  PEDIATRIC NEPHROLOGY


Minerva Pediatrica 2012 April;64(2):197-203

language: English

Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment

Oh J., Kemper M. J.

Department of Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany


PDF  


Steroid sensitive (minimal change) nephrotic syndrome (MCNS) has been regarded as immunological disorder because of clinical and experimental evidence as well as the response to immunosuppressive treatment. Recent work increased dramatically the understanding of podocyte biology which may be the key structure involved in MCNS, Interestingly many treatment options which were thought to work via an immunosuppressive pathway are now known to have a direct –non immunological- impact on the glomerular filtration barrier, i.e. the podocyte. Aim of this review is the presentation of recent research regarding the podocyte biology but also concerning the treatment of this disorder.

top of page

Publication History

Cite this article as

Corresponding author e-mail

Kemper@uke.de